Of further note, it has been recently demonstrated that low-normal thyroid function may promote plasma cholesteryl ester transfer protein-mediated cholesteryl ester transfer, and results in impaired ability of HDL to inhibit oxidative modification of LDL, both reflecting pro-atherogenic alterations in lipoprotein-associated processes. This evidence concerns the gene CETP and thyroid gland disorder.